Recommend Human Vaccines to your librarian for 2008. Download form here.
Email this page
Print this page
Research Paper
Influenza vaccine for high-risk non-elderly adults: A national survey of subspecialists
Matthew M. Davis, Pascale M. Wortley, Serigne M. Ndiaye, Anne E. Cowan, Amanda D. Osta and Sarah J. Clark
volume 4 | issue 3
may/june 2008Pages: 229 - 233
Subscribe to this journal for $79/year
Despite long-standing recommendations for non-elderly adults with certain chronic pulmonary, cardiovascular, and metabolic conditions to receive influenza vaccine, vaccination rates remain low. Visits to subspecialists represent an important vaccination opportunity, but little is known regarding subspecialists’ perceptions related to influenza vaccination. In February 2003, we conducted a cross-sectional mail survey of a random sample (N = 2,007) of board-certified cardiologists, endocrinologists, and pulmonologists from the entire United States who provided outpatient care to adults aged 18-64 years, to assess their patterns of and attitudes toward administering influenza vaccine to high-risk, non-elderly patients. The overall response rate was 33%. Among 621 eligible respondents, 483 stocked influenza vaccine in their practice (Stockers) and 138 did not stock the vaccine (Non-Stockers). Pulmonologists were most likely to stock vaccine and strongly recommend vaccination; cardiologists were least likely. Among Stockers, barriers to vaccination varied by subspecialty. Among Non-Stockers, the most common factor in the decision to not stock vaccine was the perception that patients will receive the vaccine elsewhere. Most subspecialists who provide care to a large proportion of high-risk, non-elderly persons recommend influenza vaccination to some degree, particularly pulmonologists. To reduce missed opportunities overall, subspecialists should be encouraged to vaccinate patients who say that they plan to get the vaccine elsewhere. For cardiologists in particular, barriers to stocking influenza vaccine and recommending vaccination more strongly must be addressed.
Authors
Matthew M. Davis
University of Michigan, Ann Arbor, Michigan USA
Pascale M. Wortley
National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention; Atlanta, Georgia USA
Serigne M. Ndiaye
National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention; Atlanta, Georgia USA
Anne E. Cowan
University of Michigan, Ann Arbor, Michigan USA
Amanda D. Osta
University of Michigan, Ann Arbor, Michigan USA
Sarah J. Clark
University of Michigan, Ann Arbor, Michigan USA